Temporal and geographical patterns of nitazene detections in drug samples and biospecimens in the United States, 2019-2024. [PDF]
Zhu DT +3 more
europepmc +1 more source
Mining of Respiratory System Toxicity Risk Signals for Fulvestrant Based on the Tianjin Adverse Reaction Monitoring Center and the FDA Adverse Event Reporting System Database. [PDF]
Wang M, Han Q, Jiang Y, Liang G, Yang F.
europepmc +1 more source
The rising wave of cathinone use in people attending harm reduction facilities: a French repeated cross-sectional study (2019-2023). [PDF]
de Ternay J, Plasse A, Rolland B.
europepmc +1 more source
Non-fatal drug overdose surveillance using hospital discharge data: a comparison between the Drug Overdose Surveillance and Epidemiology (DOSE) system and the Healthcare Cost and Utilisation Project, 18 states, 2018-2020. [PDF]
Quader ZS +4 more
europepmc +1 more source
Long-term efficacy of the treat-to-close strategy for patients with atrial septal defect-pulmonary artery hypertension and characteristics of indicated populations. [PDF]
Fan J +10 more
europepmc +1 more source
Identifying Subgroups of People Living With HIV in British Columbia, Canada Based on Sexually Transmitted and Blood-Borne Infection Testing and Diagnostic Laboratory Data: A Retrospective Cohort Study. [PDF]
Yonkman AM +6 more
europepmc +1 more source
Physician Perspectives on Web-Based Real-World Statistics for Better-Informed Drug Selection in Epilepsy: Mixed Methods Study. [PDF]
Larsson D +3 more
europepmc +1 more source
Barriers and facilitators to implementing a shared decision-making tool for anticoagulant-related drug-drug interactions: a qualitative study across three academic medical centres in the USA. [PDF]
Becker RA +14 more
europepmc +1 more source
Explaining the experiences of stakeholders in design evaluation criteria for the electronic prescribing system in Iran: a qualitative study. [PDF]
Vejdani M +6 more
europepmc +1 more source

